000056252 001__ 56252
000056252 005__ 20170327111930.0
000056252 0247_ $$2doi$$a10.1155/2015/813242
000056252 0248_ $$2sideral$$a91443
000056252 037__ $$aART-2015-91443
000056252 041__ $$aeng
000056252 100__ $$aGarcia-Medina, J.
000056252 245__ $$aDoes posterior capsule opacification affect the results of diagnostic technologies to evaluate the retina and the optic disc?
000056252 260__ $$c2015
000056252 5060_ $$aAccess copy available to the general public$$fUnrestricted
000056252 5203_ $$aThe visual outcome obtained after cataract removal may progressively decline because of posterior capsular opacification (PCO). This condition can be treated by creating an opening in the posterior lens capsule by Nd:YAG laser capsulotomy. PCO optical imperfections cause several light reflection, refraction, and diffraction phenomena, which may interfere with the functional and structural tests performed in different ocular locations for the diagnosis and follow-up of ocular disease, like macular and optic nerve diseases. Some parameters measured by visual field examinations, scanning laser polarimetry, and optical coherence tomography (OCT) have changed after PCO removal. Imaging quality also changes following capsulotomy. Consequently, the results of ancillary tests in pseudophakic eyes for studying ocular diseases like glaucoma or maculopathies should be correlated with other clinical examinations, for example, slit-lamp biomicroscopy or funduscopy. If PCO is clinically significant, a new baseline should be set for future comparisons following capsulotomy when using automated perimetry and scanning laser polarimetry. To perform OCT in the presence of PCO, reliable examinations (considering signal strength) apparently guarantee that measurements are not influenced by PCO.
000056252 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000056252 590__ $$a2.134$$b2015
000056252 591__ $$aMEDICINE, RESEARCH & EXPERIMENTAL$$b72 / 124 = 0.581$$c2015$$dQ3$$eT2
000056252 591__ $$aBIOTECHNOLOGY & APPLIED MICROBIOLOGY$$b81 / 161 = 0.503$$c2015$$dQ3$$eT2
000056252 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000056252 700__ $$aDel Rio-Vellosillo, M.
000056252 700__ $$aZanon-Moreno, V.
000056252 700__ $$aSantos-Bueso, E.
000056252 700__ $$aGallego-Pinazo, R.
000056252 700__ $$0(orcid)0000-0002-2914-2593$$aFerreras, A.$$uUniversidad de Zaragoza
000056252 700__ $$aPinazo-Duran, M.
000056252 7102_ $$11004$$2646$$aUniversidad de Zaragoza$$bDepartamento de Cirugía, Ginecología y Obstetricia$$cOftalmología
000056252 773__ $$g2015 (2015), 813242 [8 pp]$$pBioMed res. int.$$tBioMed Research International$$x2314-6133
000056252 8564_ $$s1632764$$uhttp://zaguan.unizar.es/record/56252/files/texto_completo.pdf$$yVersión publicada
000056252 8564_ $$s91021$$uhttp://zaguan.unizar.es/record/56252/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000056252 909CO $$ooai:zaguan.unizar.es:56252$$particulos$$pdriver
000056252 951__ $$a2016-07-25-09:48:41
000056252 980__ $$aARTICLE